Lv11
50 积分 2025-04-09 加入
Asthma
1小时前
已完结
Consensus of an American College of Allergy, Asthma, and Immunology, American Academy of Allergy, Asthma, and Immunology, and American Thoracic Society workgroup on definition of clinical remission in asthma on treatment
2小时前
已完结
Lunsekimig's bispecific targeting of IL-13 and TSLP in asthma: dual targets for synergistic effects?
24天前
已完结
Diagnosis and treatment options for T2-low asthma
24天前
已完结
2025 American Thoracic Society International Conference
1个月前
已关闭
Navigating First‐in‐Human and Early‐Phase Patient Studies: Study Designs, Risk Mitigation, and Population Selection Challenges
1个月前
已完结
Who really responds to asthma biologics? The clue lies in the journey before treatment
1个月前
已完结
Concurrent Blood Eosinophils and FeNO as Biological Therapy Indicators in Severe Asthma: Findings from the PRISM study
1个月前
已完结
A novel endpoint for exacerbations in asthma to accelerate clinical development: a post-hoc analysis of randomised controlled trials
3个月前
已关闭
Evaluating tezepelumab for COPD: a missed target or unmet potential?
3个月前
已完结
皖公网安备34019202002308
